Novel [(biphenyloxy)propyl]isoxazole derivatives for inhibition of human rhinovirus 2 and coxsackievirus B3 replication

Journal of Antimicrobial Chemotherapy

Volumn 55, Issue 4, 2005, Pages 483-488

  Makarov, Vadim A ^a   Riabova, Olga B ^a   Granik, Vladimir G ^a   Wutzler, Peter ^b   Schmidtke, Michaela ^b  

^a National Research Centre of Antibiotics   (Russian Federation)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Antivirals; Biphenyls; Coxsackieviruses; Picornaviruses; Rhinoviruses; Suzuki reaction

Indexed keywords

1 METHYL 2 PYRROLIDINONE; 2,6 DIMETHYL 4 BROMOPHENOL; 5 [3 (4 BROMO 2,6 DIMETHYLPHENOXY)PROPYL] 3 METHYLISOXAZOLE; 5 [3 (4 BROMO 2,6 DIMETHYLPHENYLPHENOXY)PROPYL] 3 METHYLISOXAZOLE; 5 BROMO 1,3 DIMETHYL 2 (4 PENTYNYLOXY)BENZENE; [(BIPHENYLOXY)PROPYL]ISOXAZOLE DERIVATIVE; BENZENE DERIVATIVE; BENZENEBORONIC ACID; BIPHENYL DERIVATIVE; CHLORIDE; DISOXARIL; METHYLACETALDOXIME; OXIME DERIVATIVE; PALLADIUM COMPLEX; PENTYN CHLORIDE; PLECONARIL; POTASSIUM CARBONATE; POTASSIUM IODIDE; TETRAKIS(TRIPHENYLPHOSPHINE) PALLADIUM; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIVIRAL ACTIVITY; ARTICLE; CHEMICAL PROCEDURES; CONTROLLED STUDY; COXSACKIE VIRUS B3; CYTOPATHOGENIC EFFECT; DRUG CYTOTOXICITY; DRUG SYNTHESIS; HELA CELL; HUMAN; HUMAN CELL; HUMAN RHINOVIRUS; HUMAN RHINOVIRUS 14; HUMAN RHINOVIRUS 2; NONHUMAN; POLYMERIZATION; SUBSTITUTION REACTION; SUZUKI REACTION; VIRUS INHIBITION; VIRUS ISOLATION; VIRUS PLAQUE; VIRUS REPLICATION; VIRUS STRAIN;

ANTIVIRAL AGENTS; ENTEROVIRUS B, HUMAN; HELA CELLS; HUMANS; ISOXAZOLES; MODELS, CHEMICAL; MOLECULAR STRUCTURE; RHINOVIRUS; VIRUS REPLICATION;

EID: 17444378657     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dki055     Document Type: Article

References (25)

1. Melnick, J. L. (1983). Portraits of viruses: the picornaviruses. Intervirology 20, 61-100.
2. Rotbart, H. A. (2002). Treatment of picornavirus infections. Antiviral Research 53, 83-98.
3. Hogle, J. M., Chow, M. & Filman, D. J. (1985). Three-dimensional structure of poliovirus at 2.9Å resolution. Science 229, 1358-65.
4. Muckelbauer, J. K., Kremer, M., Minor, I. et al. (1995). The structure of coxsackievirus B3 at 3.5Å resolution. Structure 3, 653-67.
5. Rossmann, M. G., Arnold, E., Erickson, J. W. et al. (1985). Structure of a human common cold virus and functional relationship to other picornaviruses. Nature 317, 145-53.
6. Rossmann, M. G. (1989). The structure of antiviral agents that inhibit uncoating when complexed with viral capsids. Antiviral Research 11, 3-13.
7. Rossmann, M. G. (1989). The canyon hypothesis. Viral Immunology 2, 143-61.
8. Diana, G. D. (2003). Inhibitors of picornavirus replication. Current Medicinal Chemistry 2, 1-12.
9. Diana, G. D., Rudewicz, P., Pevear, D. C. et al. (1995). Picornavirus inhibitors: trifluoromethyl substitution provides a global protective effect against hepatic metabolism. Journal of Medicinal Chemistry 38, 1355-71.
10. Diana, G. D., Rudewicz, P., Pevear, D. C. et al. (1995). WIN 63843, a metabolically stable broad spectrum antipicornaviral compound. Antiviral Research 26, A245.
11. Rogers, J. M., Diana, G. D. & McKinlay, M. A. (1999). Pleconaril. A broad spectrum antipicornaviral agent. Advances in Experimental Medicine and Biology 458, 69-76.
12. Pevear, D. C., Tull, T. M., Selpel, M. E. et al. (1999). Activity of pleconaril against enteroviruses. Antimicrobial Agents and Chemotherapy 43, 2109-15.
13. Groarke, J. M. & Pevear, D. C. (1999). Attenuated virulence of pleconaril-resistant coxsackievirus B3 variants. Journal of Infectious Diseases 179, 1538-41.
14. Guiles, J. W., Diana, G. D. & Pevear, D. C. (1995). [(Biaryloxy)alkyl]isoxazoles: picornavirus inhibitors. Journal of Medicinal Chemistry 38, 2780-3.
15. Schmidtke, M., Schnittler, U., Jahn, B. et al. (2001). A rapid assay for evaluation of antiviral activity against coxsackievirus B3, influenza virus A, and herpes simplex virus type 1. Journal of Virological Methods 95, 133-43.
16. Fuson, R. C. & Cleveland, E. A. (1940). 2,2′-Dinitrophenyl. Organic Synthesis 20, 45-7.
17. Echavarren, A. M. & Stille, J. K. (1987). Palladium-catalyzed coupling of aryl-triflates with organostananes. Journal of Organic Chemistry 109, 5478-82.
18. Farina, V., Marshall, D. R. & Roth, G. P. (1993). Palladium-catalyzed coupling of aryl-stannanes with organic sulfonates: a comprehensive study. Journal of Organic Chemistry 58, 5434.
19. Bailey, T. R. (1991). A mild, efficient approach to 3-acylfurans: a short synthesis of perilla ketone. Synthesis 2 242-3.
20. Diana, G. D., Cutcliffe, D., Oglesby, R. C. et al. (1989). Synthesis and structure-activity studies of some disubstituted phenylisoxazoles against human picornavirus. Journal of Medicinal Chemistry 32, 450-5.
21. Miyaura, M., Yamada, K., Suginome, H. et al. (1985). Novel and convenient method for the stereo- and regiospecific synthesis of conjugated alkadienes and alkenynes via the palladium-catalyzed cross-coupling reaction of 1-alkenylboranes with bromoalkenes and bromoalkynes. Journal of the American Chemical Society 107, 972-80.
22. Diana, G. D., Volkots, D. L., Nitz, T. J. et al. (1994). Oxadiazoles as ester bioisosteric replacements in compounds related to disoxaril. Antirhinovirus activity. Journal of Medicinal Chemistry 37, 2421-36.
23. Klump, W. M., Bergmann, I., Muller, B. C. et al. (1990). Complete nucleotide sequence of infectious coxsackievirus B3 cDNA: two initial 5′ uridine residues are regained during plus-strand RNA synthesis. Journal of Virology 64, 1573-83.
24. Schmidtke, M., Hammerschmidt, E., Zell, R. et al. (2004). VP1 sequence analysis and susceptibility of laboratory strains and clinical isolates of coxsackievirus B3 (CVB3) to pleconaril. Antiviral Research 62, A78.
25. Ledford, R. M., Patel, N. R., Demenczuk, T. M. et al. (2004). VP1 sequencing of all human rhinovirus serotypes: insights into genus phylogeny and susceptibility to antiviral capsid-binding compounds. Journal of Virology 78, 3663-74.